Antoni Wiedlocha funded by the EEA Poland-Norway grants
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
From the National Centre for Research and Development in Poland:
Published in major journals, first or last author from Oslo University Hospital.
Lohse AW, Sebode M, Jørgensen MH, Ytting H, Karlsen TH, Kelly D, Manns MP, Vesterhus M, European Reference Network on Hepatological Diseases (ERN RARE-LIVER) and of the International Autoimmune Hepatitis Group (IAIHG)(2020) Second-line and Third-line therapy for Autoimmune Hepatitis A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group J Hepatol(in press) DOI 10.1016/j.jhep.2020.07.023, PubMed 32707224
Edvardsen T, Cosyns B, Popescu BA, Maurer G(2020) Maurizio Galderisi (31 August 1954-27 March 2020) Eur Heart J, 41(25), 2350-2351 DOI 10.1093/eurheartj/ehaa268, PubMed 32608492
Vietri M, Schultz SW, Bellanger A, Jones CM, Petersen LI, Raiborg C, Skarpen E, Pedurupillay CRJ, Kjos I, Kip E, Timmer R, Jain A, Collas P, Knorr RL, Grellscheid SN, Kusumaatmaja H, Brech A, Micci F, Stenmark H, Campsteijn C(2020) Unrestrained ESCRT-III drives micronuclear catastrophe and chromosome fragmentation Nat Cell Biol, 22(7), 856-867 DOI 10.1038/s41556-020-0537-5, PubMed 32601372